IMMU FDA approved treatment for breast cancer.
Hello,
What is IMMU?
Immunomedics, Inc. develops, manufactures, and sells diagnostic imaging and therapeutic products. The Company's products are used to detect and treat cancer and infectious diseases. Immunomedics markets its products in the United States and Europe.
News
My Thoughts For You
Last month we have seen128% jump in price largely following the companies announcement that the Food and Drug Administration (FDA) approved its drug Trodelvy for use in metastatic triple-negative breast cancer. With that said we all know that after an impulse there will be a correction and right now we are in a correction but have not tested support and I expect the price to hit .50% level which is the weekly support area and perhaps it may wick down to the .618% fib level. This news however could change things but overall we will see price test its all-time highs very soon...given the news.
Good Luck, Cheers!
Be sure to comment, follow, like, and check out my profile for more trade ideas!
What is IMMU?
Immunomedics, Inc. develops, manufactures, and sells diagnostic imaging and therapeutic products. The Company's products are used to detect and treat cancer and infectious diseases. Immunomedics markets its products in the United States and Europe.
News
My Thoughts For You
Last month we have seen128% jump in price largely following the companies announcement that the Food and Drug Administration (FDA) approved its drug Trodelvy for use in metastatic triple-negative breast cancer. With that said we all know that after an impulse there will be a correction and right now we are in a correction but have not tested support and I expect the price to hit .50% level which is the weekly support area and perhaps it may wick down to the .618% fib level. This news however could change things but overall we will see price test its all-time highs very soon...given the news.
Good Luck, Cheers!
Be sure to comment, follow, like, and check out my profile for more trade ideas!
פרסומים קשורים
כתב ויתור
המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.